Abstract
Pharmacological profile of MK-8189, a novel phosphodiesterase 10A inhibitor, and relationship between phosphodiesterase 10A enzyme occupancy and preclinical efficacy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have